Ahsan Farooqi

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (12)

Lewis Nasr

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

B. Ashleigh Guadagnolo

Professor

MD Anderson Cancer Center

UNITED STATES

View details

Russell Witt

Assistant Professor

University of Virginia

UNITED STATES

View details

Andrew Bishop

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Nandita Guha-Thakurta

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Elise Nassif

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Anthony P. Conley

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Roi Weiser

Assistant Professor

MD Anderson Cancer Center

UNITED STATES

View details

J. Jack Lee

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ethan Ludmir

UNITED STATES

View details

Don L. Gibbons

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Debra Nana Yeboa

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ahsan Farooqi

Research Interests

Explore related searches

Contact this professor

Articles (15)

Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT‐STS): Updated local control, late toxicities, and patient‐reported outcomes

Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma

Outcomes for patients with head and neck sarcoma treated curatively with radiation therapy and surgery.

High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience

Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes

Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.

Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation

Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non–Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival

Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases

SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.

Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.

Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression.

Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma.

Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention

Collaborators (12)

Lewis Nasr

B. Ashleigh Guadagnolo

Russell Witt

Andrew Bishop

Nandita Guha-Thakurta

Elise Nassif

Anthony P. Conley

Roi Weiser

J. Jack Lee

Ethan Ludmir

Don L. Gibbons

Debra Nana Yeboa

Make your next move.